Core Laboratories (CLB) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $11.77 +0.68%
EPS Growth %: +36.4%
Financial Fact:
Income before income tax expense: 18.92M
Today's EPS Names:
JFIN, KEQU, LASE, More
EPS Growth %: +36.4%
Financial Fact:
Income before income tax expense: 18.92M
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
Core Laboratories (NYSE: CLB) reported Q2 EPS of $0.18, $0.02 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $118.7 million versus the consensus estimate of $119.38 million.
GUIDANCE:
Core Laboratories sees Q3 2021 EPS of $0.19-$0.21, versus the consensus of $0.23.
For earnings history and earnings-related data on Core Laboratories (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
- Pfizer lung cancer drug misses survival goal in Phase 3 trial
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
